Announced Tue, 10 Feb · 14:01 IST

Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve as attached

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vaxfab Enterprises has informed BSE that its Board of Directors will meet on Saturday, February 14, 2026 to consider and approve the unaudited financial results for the quarter ended December 31, 2025 (Q3 FY26). The trading window for designated persons has been closed since January 1, 2026 and will reopen 48 hours after the results are submitted. No financial figures have been disclosed in this filing — it is a routine pre-results intimation. The letter is signed by Managing Director Ravindra Ashokbhai Joshi.

Likely market impact

This is a standard advance notice with no immediate impact on shareholders. Investors should watch for the actual Q3 FY26 numbers after the February 14 board meeting, as these will be the first meaningful indicator of the company's performance this quarter.